CRISPR Therapeutics vs NFL Biosciences
CRISPR Therapeutics vs NFL Biosciences, compared side by side on 17 data points: what each one does, how big it is, what it has raised, the tech running each site, and what users report. We score both out of 100 on traction, team and visibility: CRISPR Therapeutics is on 64/100 and NFL Biosciences on 37/100.
Where each one leads
CRISPR Therapeutics
- our overall score: 64/100 against 37/100
- agent readiness: 44/100 against 21/100
- domain rating: 67/100 against 27/100
- funding raised: $547M against $15.5M
NFL Biosciences
Leads on none of the measures we hold for both companies.
At a glance
| Measure | CRISPR Therapeutics | NFL Biosciences |
|---|---|---|
| What it is | Biotechnology company developing transformative gene-based medicines using CRISPR/Cas9 gene editing technology. | Biopharmaceutical company developing innovative botanical drugs for addiction treatment. |
| Category | Biotechnology, Gene Editing, Therapeutics, Pharmaceuticals | Biotechnology, Pharmaceuticals, Healthcare |
| Sells toBusiness model | B2B | B2B |
| Offering | Platform | Services |
| Founded | 2013 | 2001 |
| Headquarters | Zug, Switzerland | Castelnau-le-Lez, France |
| Status | Active | Active |
Size, funding and growth
| Measure | CRISPR Therapeutics | NFL Biosciences |
|---|---|---|
| Total funding | $547M | $15.5M |
| Latest round | Series B | Bond Financing |
| Valuation | Not published | $20.0M |
StartupHub scores
Our own 0-100 ratings. They measure company strength and site quality, not which product suits you.
| Measure | CRISPR Therapeutics | NFL Biosciences |
|---|---|---|
| StartupHub scoreOur 0-100 rating | 64/100 | 37/100 |
| Traction | 40/100 | 36/100 |
| Team | 70/100 | 30/100 |
| Search visibility | 13/100 | 10/100 |
| Quality | 88/100 | 45/100 |
| Agent readinessHow well an AI agent can read and act on the site | D (44/100) | F (21/100) |
| Domain ratingLink authority, 0-100 | 67/100 | 27/100 |
Technology
Detected on each public site, so it reflects the marketing stack as well as the product.
| Measure | CRISPR Therapeutics | NFL Biosciences |
|---|---|---|
| Hosting | Self Managed | Self Managed |
| CMS | Not detected | WordPress |
| Frameworks | Jquery | Not detected |
| Analytics | Google Analytics 4 | Not detected |
CRISPR Therapeutics vs NFL Biosciences: common questions
Which is better, CRISPR Therapeutics or NFL Biosciences?
On our 0-100 score CRISPR Therapeutics rates higher (64/100 against 37/100). The score weights traction, team, visibility and profile completeness, so it reflects company strength rather than which product suits you. We compare the two on 17 data points above: read the rows that match what you are buying for.
How do CRISPR Therapeutics and NFL Biosciences compare on the numbers?
CRISPR Therapeutics leads on our overall score (64/100 against 37/100), agent readiness (44/100 against 21/100), domain rating (67/100 against 27/100), funding raised ($547M against $15.5M).
Read the full CRISPR Therapeutics review and pricing or the NFL Biosciences review and pricing. You can also browse other CRISPR Therapeutics alternatives we track.